Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sisterna is a specialized supplier of high-quality sucrose esters, operating as a joint venture between DKS Co. Ltd. of Japan and Royal Cosun of the Netherlands. The company focuses on providing bio-based, biodegradable emulsifiers for the pharmaceutical, personal care, and food industries. In the healthcare sector, Sisterna's sucrose esters serve as multifunctional excipients used to improve the solubility of poorly water-soluble drugs and to control the release profiles of active pharmaceutical ingredients. Their products are suitable for various dosage forms, including oral, topical, and parenteral applications. Sisterna provides extensive technical expertise and regulatory support to help clients optimize their formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sisterna.